MedTrace Logo

Creatine HCl and Creatine Ethyl Ester Supplementation in Perimenopausal and Menopausal Women

NCT06660004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-12-16

No results posted yet for this study

Summary

The goal of this randomized controlled double-blind parallel-group interventional trial is to evaluate the effects of of dietary supplementation with creatine HCl and creatine ethyl ester supplementation on cognitive performance, multidimensional fatigue, brain metabolism, and biochemical indices in perimenopausal and menopausal women

Conditions

  • Menopausal
  • Perimenopause

Interventions

DIETARY_SUPPLEMENT

Dietary Supplement: Experimental 1 Creatine HCl

Creatine hcl

DIETARY_SUPPLEMENT

Dietary Supplement: Experimental 2 Creatine HCl

Creatine hcl

DIETARY_SUPPLEMENT

Dietary Supplement: Experimental 3 Creatine Ethyl ester

Creatine ethyl ester

DIETARY_SUPPLEMENT

Dietary Supplement: Experimental 4 Placebo

Placebo

Sponsors & Collaborators

  • University of Novi Sad, Faculty of Sport and Physical Education

    lead OTHER

Principal Investigators

  • Sergej Ostojic, MD, PhD · Applied BIoenergetics Lab

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2025-05-15
Completion
2025-05-31

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06660004 on ClinicalTrials.gov